Analyst firms · Atlantic Equities · CME
Atlantic Equities CME price target and rating history
CME Group Inc. (CME) · Finance
Atlantic Equities rates CME Group Inc. (CME) Overweight with a $235 price target, as of its latest action on Jun 10, 2022. It has published 4 rating actions on CME since September 2021, including 2 upgrades and 2 downgrades. Across 5 firms with a CME price target in the last 12 months, the median target is $305.
- Current rating
- Overweight
- Price target
- $235
- Median target, all firms
- $305
- Actions on CME
- 4
Atlantic Equities price target on CME
Every Atlantic Equities rating on CME
- Jun 10, 2022
- Feb 8, 2022
- Feb 8, 2022
- Sep 14, 2021
How other firms rate CME
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Overweight | $301 | Oct 2, 2026 |
| Deutsche Bank | Hold | $270 | Aug 19, 2026 |
| Keefe, Bruyette & Woods | Outperform | $305 | Jun 18, 2026 |
| Rothschild & Co Redburn | Buy | $323 | Jun 11, 2026 |
| Erste Group | Hold | Jun 5, 2026 | |
| Argus Research | Hold | Mar 4, 2026 | |
| TD Cowen | Buy | $305 | Jan 14, 2026 |
Questions about Atlantic Equities and CME
- What is Atlantic Equities's price target for CME?
- Atlantic Equities's latest stated price target for CME Group Inc. (CME) is $235, from its action on Jun 10, 2022.
- What is Atlantic Equities's rating on CME?
- Atlantic Equities rates CME Overweight, a bullish rating, as of Jun 10, 2022.
- When did Atlantic Equities last change its view on CME?
- On Jun 10, 2022, Atlantic Equities upgrades to Overweight from Neutral, price target $235.
- How does Atlantic Equities's CME target compare with other analysts?
- Across 5 firms with a CME price target in the last 12 months, the median target is $305.
More CME rating histories
All Atlantic Equities ratingsCME news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.